(133 days)
Not Found
No
The description details a standard oscillometric blood pressure measurement method using a pressure sensor and CPU for calculation, with no mention of AI or ML algorithms.
No
The device is described as a blood pressure monitor, intended for measuring blood pressure and pulse rate. Its function is diagnostic/monitoring, not therapeutic.
Yes
The device measures adult blood pressure and pulse rate, which are physiological parameters used to assess a person's health status and can indicate potential medical conditions.
No
The device description explicitly mentions hardware components like a blood pressure cuff, air pump, pressure sensor, and CPU, indicating it is not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to measure adult blood pressure and pulse rate. This is a physiological measurement taken directly from the body, not a test performed on a sample (like blood, urine, or tissue) outside of the body.
- Device Description: The description details a pressure-based method using a cuff and sensor to measure pressure changes in the artery. This is a physical measurement, not a chemical, biological, or immunological test performed on a sample.
- Lack of IVD Characteristics: The description does not mention any reagents, assays, or analysis of biological samples, which are hallmarks of IVD devices.
Therefore, this device falls under the category of a non-invasive physiological monitoring device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
It is intended for measuring adult blood pressure and pulse rate with circumference ranging from 135 mm to 215 mm.
Product codes (comma separated list FDA assigned to the subject device)
DXN
Device Description
Blood pressure monitor is based on pressure vibration method. Blood pressure cuff use the air pump to inflate, then the arteries are extruded by the cuff with pressure. Pressure sensor collects the pressure in the cuff, and then converts it to digital signal to the CPU. Then the software calculates the systolic and diastolic blood pressure and pulse rate.
The blood pressure monitor BF2200, BF2210, BF2202, BF2212, BF2203, BF2213, BF2204, BF2214, BF2205, BF2215, BF2206, BF2216, BF2207 and BF2217 have the same basic principles, main function, performance and intended use, and they are consistent in product structure and material.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Wrist
Indicated Patient Age Range
Adult
Intended User / Care Setting
Home
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Laboratory testing was conducted to validate and verify that Blood pressure monitor met all requirements of related international standards, including electrical safety, EMC, biocompatibility, specification. Results of these tests demonstrate compliance to the requirements of the bellow consensus standards. Clinical study has been evaluated according to ANSI/AAMI SP10 and ANSI/AAMI/ISO 81060-2.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Static pressure: ±3mmHg(±0.4kPa)
Pulse: ±5%
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1130 Noninvasive blood pressure measurement system.
(a)
Identification. A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with flowing lines extending from the faces.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
October 9, 2014
Shenzhen Pump Medical System Co., Ltd. c/o Ms. Xie Qiongyu Deputy General Manager 2/f West, M-7 Sinosteel Building, Maqueling Estate Hi-tech Industrial Park Nanshan District, Shenzhen, Guangdong, 518057 CN
Re: K141416
Trade/Device Name: Blood Pressure Monitor, Model No. BF2200, BF2210, BF2202, BF2212, BF2203, BF2213, BF2204, BF2214, BF2205, BF2215, BF2206, BF2216, BF2207, BF2217 Regulation Number: 21 CFR 870.1130 Regulation Name: Non-Invasive Blood Pressure Measurement System Regulatory Class: Class II Product Code: DXN Dated: Not Dated Received: August 11, 2014
Dear Ms. Xie Qiongyu,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply
1
with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Melissa A. Torres -S
For Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known): _ K141416
Device Name: _ Blood pressure monitor
Indications for Use:
It is intended for measuring adult blood pressure and pulse rate with circumference ranging from 135 mm to 215 mm..
Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use V (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
3
K141416
Page 1 Of 6
510(k) Summary
1. Applicant
Applicant Name: SHENZHEN PUMP MEDICAL SYSTEM CO., LTD.
2/F West, M-7 Sinosteel Building, Maqueling Estate, Address:
Hi-Tech Industrial Park, Nanshan District,
Shenzhen 518057, China
Contact person:
Xie Qiongyu Name:
Phone numbers: 86-0755-26710795
Fax numbers: 86-0755-26012025
E-mail: xieqy@bpump.com.cn
Date Prepared: 2014-3-30
2. Device information
- Trade name: Blood pressure monitor
- Model No.: BF2200, BF2210, BF2201, BF2211, BF2202, BF2212, BF2203, ● BF2213, BF2204, BF2214, BF2205, BF2215, BF2206, BF2216, BF2207 and BF2217
- Regulation Description: Noninvasive blood pressure measurement system. ●
- Regulation Number: 21CFR 870.1130 ●
- Product Code: DXN
- Class: Il
- Review Panel: Cardiovascular
- Indications for Use: It is intended for measuring adult blood pressure and pulse ● rate with circumference ranging from 135 mm to 215 mm.
-
- Predicate Devices
- Noninvasive blood pressure measurement system ●
4
- K-number: K123498 ●
- Product Code: DXN
- Intended User: Home user
● Patient Population: This device is intended for use on adults.
Indications for Use: ●
The device is a digital monitor intended for use in measuring blood pressure and pulse rate in adult patient population with wrist circumference ranging from 5 1/4 inches to 8 1/2 inches (13.5 cm to 21.5 cm).
The device detects the appearance of irreqular heartbeats during measurement and gives a warning signal with readings.
● Manufactured by
Omron Healthcare, Inc.
4. Description of the device
Blood pressure monitor is based on pressure vibration method. Blood pressure cuff use the air pump to inflate, then the arteries are extruded by the cuff with pressure. Pressure sensor collects the pressure in the cuff, and then converts it to digital signal to the CPU. Then the software calculates the systolic and diastolic blood pressure and pulse rate.
The blood pressure monitor BF2200, BF2210, BF2202, BF2212, BF2203, BF2213, BF2204, BF2214, BF2205, BF2215, BF2206, BF2216, BF2207 and BF2217 have the same basic principles, main function, performance and intended use, and they are consistent in product structure and material.
5. Testing data and clinical study
Laboratory testing was conducted to validate and verify that Blood pressure monitor met all requirements of related international standards, including electrical safety, EMC, biocompatibility, specification. Results of these tests demonstrate compliance to the requirements of the bellow consensus standards. Clinical study has been evaluated according to ANSI/AAMI SP10 and ANSI/AAMI/ISO 81060-2.
5
K141416 Page 3 of 6
| Applied Standard: |
|---|
| Electrical Safety and performance requirements: |
| IEC 60601-1 |
| AAMI performance standard ANSI/AAMI SP10 |
| EN 81060-2-30 |
| Home-used medical equipment requirements and Environmental test: |
| IEC 60601-1-11 |
| Electromagnetic Compatibility Requirements: |
| EN 60601-1-2 |
| Biocompatibility Evaluation for NIBP Cuff |
| ISO 10993-1, ISO 10993-5, ISO 10993-10 |
| Clinical Evaluation: |
| ANSI/AAMI SP10 |
| ANSI/AAMI/ISO 81060-2 |
Conclusion:
According to above information, comparing to the predicate, the subject devices do not constitute a new intended use, and used same the Measuring Principle, same electrical noninvasive blood pressure measurement technologic and same measurement site (measuring on wrist).
The subject devices have been evaluated to meet IEC 60601-1, IEC 60601-12, AAMI/ANSI SP10, EN 80601-2-30, ISO 10993-5, and ISO 10993-10. The related test reports and clinical study reports demonstrate and do not raise different questions of safety and effectiveness than the predicate.
As a result, the subject device is Substantially Equivalent (SE) to the predicate device which is US legally market device.
6
K141416
Page 4 of 6
| Parameter | Name: Blood Pressure Monitor
Model No.:
BF2200, BF2210, BF2201, BF2211, BF2202, BF2212, BF2203,
BF2213, BF2204, BF2214, BF2205, BF2215, BF2206, BF2216,
BF2207 and BF2217 | Name: Noninvasive Blood Pressure Measurement System (K123498)
Model No.: BP652N (HEM-6300-Z) |
|-------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended use | Measurement of human blood pressure and pulse rate for adults. | The device is a digital monitor intended for use in measuring blood
pressure and pulse rate in adult patient population with wrist
circumference ranging from 5 1/4 inches to 8 1/2 inches (13.5 cm to 21.5
cm).
The device detects the appearance of irregular heartbeats during
measurement and gives a warning signal with readings. |
| Patient
Population | Adult | Adult |
| Environment of
Use | Home | Home |
| Technology | Oscillometric method | Oscillometric method |
| Anatomical sites | Wrist | Wrist |
| Measurement
range | Blood pressure: 0mmHg280mmHg37.3kPa)
(0kPa
Pulse: 40 pulse/min 180 pulse/min | Blood pressure: 0mmHg299mmHg
(0kPa~39.9kPa)
Pulse: 40 pulse/min ~180 pulse/min |
| Measurement
accuracy | Static pressure: ±3mmHg(±0.4kPa)
Pulse: ±5% | Static pressure: ±3mmHg(±0.4kPa)
Pulse: ±5% |
6. Comparison to Predicate Devices
7
| Parameter | Name: Blood Pressure Monitor
Model No.:
BF2200, BF2210, BF2201, BF2211, BF2202, BF2212, BF2203,
BF2213, BF2204, BF2214, BF2205, BF2215, BF2206, BF2216,
BF2207 and BF2217 | Name: Noninvasive Blood Pressure Measurement System (K123498)
Model No.: BP652N (HEM-6300-Z) |
|--------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------|
| Display | LCD | LCD |
| Power source | 2AAA Alkaline batteries | 2AAA Alkaline batteries |
| Operating
environment | Temperature: +5 °C~+40 °C
Humidity: ≤93% | Temperature: +10°C~+40°C
Humidity: 15%85% |+70 °C
| Storage
environment | Temperature: -25 °C
Humidity: 10%95% | Temperature: -20 °C+60 °C
Humidity: 10%~95% |
The subject device is Substantially Equivalent (SE) to the predicate device which is US legally market device.
8
K141416 Page 6 of 6
7. Conclusion
As stated above, the Blood pressure monitors (Models: BF2200, BF2210, BF2201, BF2211, BF2202, BF2212, BF2203, BF2213, BF2204, BF2214, BF2205, BF2215, BF2206, BF2216, BF2207 and BF2217) are safe and effective, and comply with the appropriate medical device standards. And they are substantially equivalent to the earlier identified predicate devices.